Sara Hetzel

Sara Hetzel

Auto-generated profile, based on publicly available information

Sara Hetzel

Department of Genome Regulation, Max Planck Institute for Molecular Genetics, Berlin, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2024 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
ZSZachary D. Smith
Zachary D. Smith
SHSara Hetzel
Sara Hetzel
AMAlexander Meissner
Alexander Meissner

21 July 2022 in Nature Genetics
Verified
Journal Article
Open access
PDF file
VAVahid Asimi
Vahid Asimi
AKAbhishek Sampath Kumar
Abhishek Sampath Kumar
HNHenri Niskanen
Henri Niskanen
CRChristina Riemenschneider
Christina Riemenschneider
SHSara Hetzel
Sara Hetzel
DHDenes Hnisz
Denes Hnisz
Most endogenous retroviruses (ERVs) in mammals are incapable of retrotransposition; therefore, why ERV derepression is associated with lethality during early development has been a mystery. Here, we report that rapid and selective degradation of the heterochromatin adapter protein TRIM28 triggers dissociation of transcriptional condensates from loci encoding super-enhancer (SE)-driven pluripotency genes and their association with transcribed ERV loci in murine embryonic stem cells. Knockdown of ERV RNAs or forced expression of SE-enriched transcription factors rescued condensate localization at SEs in TRIM28-degraded cells. In a biochemical reconstitution system, ERV RNA facilitated partitioning of RNA polymerase II and the Mediator coactivator into phase-separated droplets. In TRIM28 knockout mouse embryos, single-cell RNA-seq analysis revealed specific depletion of pluripotent lineages. We propose that coding and noncoding nascent RNAs, including those produced by retrotransposons, may facilitate ‘hijacking’ of transcriptional condensates in various developmental and disease contexts.

29 September 2022 in Cell
Verified
Journal Article
Open access
ARAlessa R. Ringel
Alessa R. Ringel
QSQuentin Szabo
Quentin Szabo
ACAndrea M. Chiariello
Andrea M. Chiariello
KCKonrad Chudzik
Konrad Chudzik
RSRobert Schöpflin
Robert Schöpflin
MRMichael I. Robson
Michael I. Robson
Regulatory landscapes drive complex developmental gene expression, but it remains unclear how their integrity is maintained when incorporating novel genes and functions during evolution. Here, we investigated how a placental mammal-specific gene, Zfp42, emerged in an ancient vertebrate topologically associated domain (TAD) without adopting or disrupting the conserved expression of its gene, Fat1. In ESCs, physical TAD partitioning separates Zfp42 and Fat1 with distinct local enhancers that drive their independent expression. This separation is driven by chromatin activity and not CTCF/cohesin. In contrast, in embryonic limbs, inactive Zfp42 shares Fat1’s intact TAD without responding to active Fat1 enhancers. However, neither Fat1 enhancer-incompatibility nor nuclear envelope-attachment account for Zfp42’s unresponsiveness. Rather, Zfp42’s promoter is rendered inert to enhancers by context-dependent DNA methylation. Thus, diverse mechanisms enabled the integration of independent Zfp42 regulation in the Fat1 locus. Critically, such regulatory complexity appears common in evolution as, genome wide, most TADs contain multiple independently expressed genes.

19 May 2022 in Nature Cancer
Verified
Journal Article
Open access
PDF file
SHSara Hetzel
Sara Hetzel
AMAlexandra L. Mattei
Alexandra L. Mattei
HKHelene Kretzmer
Helene Kretzmer
CQChunxu Qu
Chunxu Qu
XCXiang Chen
Xiang Chen
AMAlexander Meissner
Alexander Meissner
DNA methylation is tightly regulated during development and is stably maintained in healthy cells. In contrast, cancer cells are commonly characterized by a global loss of DNA methylation co-occurring with CpG island hypermethylation. In acute lymphoblastic leukemia (ALL), the commonest childhood cancer, perturbations of CpG methylation have been reported to be associated with genetic disease subtype and outcome, but data from large cohorts at a genome-wide scale are lacking. Here, we performed whole-genome bisulfite sequencing across ALL subtypes, leukemia cell lines and healthy hematopoietic cells, and show that unlike most cancers, ALL samples exhibit CpG island hypermethylation but minimal global loss of methylation. This was most pronounced in T cell ALL and accompanied by an exceptionally broad range of hypermethylation of CpG islands between patients, which is influenced by TET2 and DNMT3B. These findings demonstrate that ALL is characterized by an unusually highly methylated genome and provide further insights into the non-canonical regulation of methylation in cancer.

6 April 2023 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
RWRaha Weigert
Raha Weigert
SHSara Hetzel
Sara Hetzel
NBNina Bailly
Nina Bailly
CHChuck Haggerty
Chuck Haggerty
IIIbrahim A. Ilik
Ibrahim A. Ilik
AMAlexander Meissner
Alexander Meissner
DNA and Histone 3 Lysine 27 methylation typically function as repressive modifications and operate within distinct genomic compartments. In mammals, the majority of the genome is kept in a DNA methylated state, whereas the Polycomb repressive complexes regulate the unmethylated CpG-rich promoters of developmental genes. In contrast to this general framework, the extra-embryonic lineages display non-canonical, globally intermediate DNA methylation levels, including disruption of local Polycomb domains. Here, to better understand this unusual landscape’s molecular properties, we genetically and chemically perturbed major epigenetic pathways in mouse trophoblast stem cells. We find that the extra-embryonic epigenome reflects ongoing and dynamic de novo methyltransferase recruitment, which is continuously antagonized by Polycomb to maintain intermediate, locally disordered methylation. Despite its disorganized molecular appearance, our data point to a highly controlled equilibrium between counteracting repressors within extra-embryonic cells, one that can seemingly persist indefinitely without bistable features typically seen for embryonic forms of epigenetic regulation.

7 June 2024 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
JBJulia Batki
Julia Batki
SHSara Hetzel
Sara Hetzel
DSDennis Schifferl
Dennis Schifferl
ABAdriano Bolondi
Adriano Bolondi
MWMaria Walther
Maria Walther
AMAlexander Meissner
Alexander Meissner
Despite a distinct developmental origin, extraembryonic cells in mice contribute to gut endoderm and converge to transcriptionally resemble their embryonic counterparts. Notably, all extraembryonic progenitors share a non-canonical epigenome, raising several pertinent questions, including whether this landscape is reset to match the embryonic regulation and if extraembryonic cells persist into later development. Here we developed a two-colour lineage-tracing strategy to track and isolate extraembryonic cells over time. We find that extraembryonic gut cells display substantial memory of their developmental origin including retention of the original DNA methylation landscape and resulting transcriptional signatures. Furthermore, we show that extraembryonic gut cells undergo programmed cell death and neighbouring embryonic cells clear their remnants via non-professional phagocytosis. By midgestation, we no longer detect extraembryonic cells in the wild-type gut, whereas they persist and differentiate further in p53-mutant embryos. Our study provides key insights into the molecular and developmental fate of extraembryonic cells inside the embryo.